4/A

FORM 4/A SUBMISSION

Company: Amphastar Pharmaceuticals, Inc.
Filed: February 3, 2016
Period of Report: June 15, 2015
Accession Number: 0000899243-16-012656

View Document ↗ View on SEC.gov ↗